KURVE TECHNOLOGY, INC. (WA)
Registration and award facts
SAM.gov registration as of
- Net obligations since FY2019
- $56K
- $56,000under this UEI
- FY2026 obligations
- $0†
- Provisional
- Awards and orders
- 1
- with positive net obligations
- Latest action
- Mar 20, 2019
- SAM.gov registration
- Active
- Registration expiration date Mar 17, 2027
Registration
- Doing business as
- KURVE TECHNOLOGY INC
- Business start date
- Jan 1, 2002 (24 years)
- Location
- Lynnwood, WA
- Website
- kurvetx.com
† FY2026 obligations (provisional; DoD awards signed after Jul 26, 2026 are not yet public).
Contract actions that the Department of Defense both funds and awards are withheld at the source for 90 days, so DoD awards signed after Jul 26, 2026 are not yet public.
Source: SAM.gov entity registration and FPDS contract actions recorded under UEI NFNBUWKGA9J4. GovChime does not check exclusions.
Performance
Net obligations recorded under this UEI since FY2019. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.
Net obligations by fiscal year of action
- FY2019: $56,000
Total across 1 fiscal year: $56,000
Top awarding agencies
- Department of Defense$56,000, 100%
Top awarding sub-agencies
- Department of the Army$56,000, 100%
Top NAICS by obligations
- 339112Surgical and medical instrument manufacturing$56,000, 100%
Top product and service codes by obligations
- 6515Medical and surgical instruments, equipment, and supplies$56,000, 100%
Capabilities
NAICS codes
Small: small business for that NAICS, self-certified in SAM.gov registration.
SBA certifications
No certification in the SBA profile data.
Federal Capability Statement
Kurve Technology offers pharmaceutical and health & beauty companies versatile, cost-effective and compact liquid drug delivery devices for local, systemic, and nose-to-brain therapies. Invented by a long-time rhinosinusitis and allergy-sufferer, Kurve's drug delivery technologies offer an effective way to deliver both small and large molecule formulations. Controlled Particle Dispersion is a patented technology with proven results in clinical trials and scientific studies. Kurve continues to broaden its intellectual property portfolio in drug delivery technologies by expanding patent claims and by performing clinical trials at leading academic institutions.
Capabilities & Services
Contracts
Latest awards and orders
- W81XWH19P0031Purchase orderDepartment of DefenseDepartment of the ArmyLatest action
Contact Info
As of . Source: SAM.gov Points of Contact.
SAM.gov registration for KURVE TECHNOLOGY, INC. lists a physical address and a separate mailing address, along with 2 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.
Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).
Physical Address
723 191ST ST SW
LYNNWOOD, WA, 98036
USA
Mailing Address
16825 48TH AVE W
SUITE 434
LYNNWOOD, WA, 98037
USA
Government Business Contact
MARC GIROUX
CEO
16825 48TH AVE W
SUITE 434
LYNNWOOD, WA, 98037
USA
Government Business Alternate Contact
MARC GIROUX
CEO
16825 48TH AVE W
SUITE 434
LYNNWOOD, WA, 98037
USA
Additional Details
As of . Source: SAM.gov Entity Registration.
KURVE TECHNOLOGY, INC. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires March 17, 2027.
Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.
Compliance & Risk Assessment
Source: SAM.gov FAR responsesSuspension/Debarment Status
SAM.gov registration reports no active exclusion
Public Display
Entity information is publicly displayed
Registration Details
Source: SAM.govInitial Registration
Last Update
Registration Activation
Fiscal Year End
Country of Incorporation
Congressional District
Other contractors in Washington with primary NAICS 541714
- Primary Bioscience, Inc.Seattle, WA
- A-Alpha Bio IncSeattle, WA
- Adaptive Biotechnologies CorporationSeattle, WA
- Parse Biosciences, Inc.Seattle, WA
- Modus Health LLCMountlake Terrace, WA
- JW3 Biotechnologies LLCBothell, WA